Novartis Ag (NVS) Net Income towards Common Stockholders (2009 - 2026)

Novartis Ag has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $3.3 billion in Q2 2026.

• Quarterly Net Income towards Common Stockholders fell 92.23% year-over-year to $3.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.3 billion (down 96.21% YoY) and the FY2025 annual result came in at $14.0 billion, down 68.25% from the prior year.
• Net Income towards Common Stockholders fell to $3.3 billion in Q2 2026 per NVS's latest filing, from $42.0 billion in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $34001.4 billion in Q1 2022 and troughed at $144.0 million in Q1 2023.
• A 5-year average of $2862.8 billion and a median of $43.0 billion in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders surged 142.84% in 2022, then plunged 100.0% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at $59.3 billion in 2022, then retreated by 21.36% to $46.7 billion in 2023, then dropped by 5.62% to $44.0 billion in 2024, then dropped by 4.68% to $42.0 billion in 2025, then plunged by 92.23% to $3.3 billion in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $3.3 billion, $42.0 billion, and $44.0 billion for Q2 2026, Q2 2025, and Q4 2024 respectively.